Following two previous bariatric surgeries elsewhere, a 45-year-old woman undergoes a revision to a distal gastric bypass with outstanding results.
Attend the 12th Annual Cleveland Clinic Obesity Summit, Sept. 28-29, to hear about pharmacologic management, behavioral and lifestyle modification, and surgery.
Cleveland Clinic researchers are heading the first long-term study to evaluate the effectiveness of bariatric surgery compared with medical therapy for treating Type 2 diabetes.
From new data on the causes of obesity to alternative treatments to new medications, join us for the latest insights at the 11th Annual Obesity Summit in Cleveland.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Are medication and lifestyle changes failing to get type 2 diabetes in control? New clinical guidelines make bariatric surgery a standard treatment option for diabetics with mild obesity.
In carefully selected adolescents with severe obesity, bariatric surgery is safe and effective and offers clinical and psychosocial benefits that can last a lifetime.
Five-year results from the pivotal STAMPEDE trial confirm those of interim reports, with bariatric surgery’s advantage over intensive medical therapy for diabetes appearing to widen over time.
Cleveland Clinic study finds gastric bypass surgery is a viable option for obese patients and should be considered early in the course of type 2 diabetes treatment.
Attend the 10th Annual Cleveland Clinic Obesity Summit, Oct. 2-3, to hear about progress made in obesity management and to gain insights into surgery, lifestyle interventions, medications and the rise in childhood obesity.
Innovative solutions to the causes of obesity, preventive strategies and therapeutic management approaches are among the topics at the 10th Annual Cleveland Clinic Obesity Summit, Oct. 2-3.